Rhenman & Partners Asset Management Ab Jazz Pharmaceuticals PLC Transaction History

Rhenman & Partners Asset Management Ab

$1.01 Billion
Q2 2024

A detailed history of Rhenman & Partners Asset Management Ab transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Rhenman & Partners Asset Management Ab holds 114,000 shares of JAZZ stock, worth $12.5 Million. This represents 1.2% of its overall portfolio holdings.

Number of Shares

114,000

Previous 146,729 22.31%

Holding current value

$12.5 Million

Previous $17.7 Million 31.14%

% of portfolio

1.2%

Previous 1.73%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$103.94 - $118.98 $3.4 Million - $3.89 Million	-32,729 Reduced 22.31%	114,000 $12.2 Million
Q1 2024 May 14, 2024	BUY	$115.19 - $132.77 $2.66 Million - $3.07 Million	23,095 Added 18.68%	146,729 $17.7 Million
Q4 2023 Feb 13, 2024	SELL	$114.26 - $136.0 $2.29 Million - $2.72 Million	-20,000 Reduced 13.92%	123,634 $15.2 Million
Q3 2023 Nov 13, 2023	BUY	$122.0 - $145.31 $8.86 Million - $10.6 Million	72,634 Added 102.3%	143,634 $18.6 Million
Q3 2023 Nov 09, 2023	SELL	$122.0 - $145.31 $9.03 Million - $10.8 Million	-74,000 Reduced 51.03%	71,000 $9.19 Million
Q2 2023 Aug 11, 2023	SELL	$122.5 - $147.16 $612,500 - $735,800	-5,000 Reduced 3.33%	145,000 $18 Million
Q1 2023 May 11, 2023	BUY	$133.98 - $160.47 $2.95 Million - $3.53 Million	22,000 Added 17.19%	150,000 $21.9 Million
Q4 2022 Feb 13, 2023	SELL	$129.72 - $159.85 $454,020 - $559,475	-3,500 Reduced 2.66%	128,000 $20.4 Million
Q3 2022 Nov 14, 2022	SELL	$126.59 - $161.18 $3.61 Million - $4.59 Million	-28,500 Reduced 17.81%	131,500 $18.9 Million
Q2 2022 Aug 12, 2022	SELL	$141.59 - $168.66 $3.11 Million - $3.71 Million	-21,976 Reduced 12.08%	160,000 $25 Million
Q1 2022 May 13, 2022	SELL	$129.64 - $160.7 $14 Million - $17.4 Million	-108,024 Reduced 37.25%	181,976 $28.3 Million
Q4 2021 Feb 11, 2022	BUY	$119.87 - $145.67 $1.2 Million - $1.46 Million	10,000 Added 3.57%	290,000 $37.2 Million
Q3 2021 Nov 12, 2021	BUY	$128.64 - $184.79 $7.72 Million - $11.1 Million	60,000 Added 27.27%	280,000 $36.5 Million
Q2 2021 Aug 13, 2021	SELL	$160.2 - $186.42 $4.81 Million - $5.59 Million	-30,000 Reduced 12.0%	220,000 $39.1 Million
Q1 2021 May 14, 2021	BUY	$150.19 - $173.5 $4.51 Million - $5.21 Million	30,000 Added 13.64%	250,000 $41.1 Million
Q4 2020 Jan 19, 2021	BUY	$140.71 - $165.05 $7.04 Million - $8.25 Million	50,000 Added 29.41%	220,000 $36.3 Million
Q3 2020 Oct 13, 2020	BUY	$105.46 - $144.13 $3.48 Million - $4.75 Million	32,968 Added 24.06%	170,000 $24.2 Million
Q2 2020 Jul 16, 2020	BUY	$95.68 - $121.88 $1.63 Million - $2.08 Million	17,032 Added 14.19%	137,032 $15.1 Million
Q1 2020 Apr 16, 2020	BUY	$87.74 - $152.74 $1.68 Million - $2.93 Million	19,195 Added 19.04%	120,000 $12 Million
Q4 2019 Jan 17, 2020	SELL	$117.65 - $153.73 $5.79 Million - $7.56 Million	-49,195 Reduced 32.8%	100,805 $15 Million
Q3 2019 Oct 16, 2019	SELL	$125.18 - $143.24 $4.65 Million - $5.32 Million	-37,171 Reduced 19.86%	150,000 $19.2 Million
Q1 2019 Apr 11, 2019	BUY	$121.81 - $142.95 $2.6 Million - $3.05 Million	21,353 Added 12.88%	187,171 $26.8 Million
Q4 2018 Feb 05, 2019	BUY	$115.94 - $166.74 $4.58 Million - $6.59 Million	39,496 Added 31.27%	165,818 $20.6 Million
Q3 2018 Oct 03, 2018	SELL	$161.01 - $180.57 $340,375 - $381,724	-2,114 Reduced 1.65%	126,322 $21.2 Million
Q2 2018 Jul 20, 2018	SELL	$146.33 - $183.18 $2.93 Million - $3.66 Million	-20,000 Reduced 13.47%	128,436 $22.1 Million
Q1 2018 Apr 11, 2018	BUY	$135.59 - $157.16 $2.03 Million - $2.36 Million	15,000 Added 11.24%	148,436 $22.4 Million
Q4 2017 Jan 19, 2018	BUY	$131.06 - $150.39 $6.35 Million - $7.28 Million	48,436 Added 56.98%	133,436 $18 Million
Q3 2017 Oct 13, 2017	BUY	$142.62 - $155.6 $12.1 Million - $13.2 Million	85,000	85,000 $12.4 Million

Others Institutions Holding JAZZ

# of Institutions

498

Shares Held

57.4M

Call Options Held

155K

Put Options Held

152K

View Full List

About Jazz Pharmaceuticals plc

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $6.9B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

More about JAZZ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhenman & Partners Asset Management Ab, based on Form 13F filings with the SEC.

News

Stay updated on Rhenman & Partners Asset Management Ab with notifications on news.

Account

Rhenman & Partners Asset Management Ab Jazz Pharmaceuticals PLC Transaction History